Investor Type | Firm |
Industries | IT (& TMT) • Media • BioTech • Hardware (& Manufacturing) • Energy • HealthTech (& Fitness) • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Investment Management • Life Science • Oncology |
Investing | United States |
Easton Capital Investment Group is a New York-based venture capital fund that primarily focuses on the healthcare and life sciences sectors. They champion investments in companies engaged in healthcare, information technology, diagnostics, therapeutics, biotechnology, IT, Media, BioTech, Hardware, Manufacturing, Energy, HealthTech, Fitness, Logistics, Distribution, Medical Devices, Hospital Services, Healthcare, Wellness, Investment Management, Life Science, and Oncology. Easton Capital takes a classical approach to venture capital, aiming to invest in opportunities that offer services or products that substantially improve healthcare delivery or reduce its cost. They emphasize structured transactions to maximize potential returns and minimize risks, favoring capital-efficient business models that typically require no more than an additional $10-20 million to reach the market, become cash flow positive, or be prepared for acquisition. Their investment philosophy is grounded in aligning their interests with those of entrepreneurs and managers, striving to maximize returns while minimizing risks using the lowest reasonable capital base, thus ensuring minimal dilution. The firm boasts a seasoned team with a broad range of expertise in science, technology, clinical affairs, investment, operations, and business development. Their team members have managed over $1 billion in investment funds, assisted in the launch of over 100 companies, and made multiple investments with 100x returns. Easton Capital takes pride in its commitment to diversity, with 40% of CEOs or Founders in its latest fund being women, and several successful investments led by female executives. The significant markers of their success also include several portfolio companies reaching or exceeding valuations of over $1 billion.